Research services

Clinical medical writing

Clinical medical writing for clinical trials develops high-quality, regulatory-ready clinical documents to support global approvals, with a focus on delivering fast, accurate, and compliant trial reports and submission materials.

Hybrid studies

Hybrid studies combine newly collected primary data with existing secondary sources for rich, comprehensive evidence.

Product and disease registries

Product and disease registries provide comprehensive evaluation of safety, effectiveness, and health trends with long-term databases that support tracking outcomes for specific diseases or treatments using primary and secondary data.

Clinical trial design

Oracle Life Sciences Voices to Trials transforms patient and provider insights into strategies that help enhance trial design, boost recruitment, support retention, and facilitate relevance and inclusivity.

Natural history of disease studies

Natural disease history studies provide longitudinal understanding of disease progression through non-interventional research. These studies help uncover patterns and predictors to inform future research and support proactive care.

Real-world evidence

Site-based, non-interventional, real-world evidence uncovers insights into patient care outcomes, patterns, and populations—generated through observational studies conducted at healthcare facilities.

Drug utilization studies

Drug utilization studies conduct in-depth analysis of how and when medications are used in real-world settings to identify meaningful trends.

Phase IV post-authorization safety and efficacy studies

Phase IV post-authorization safety and post-authorization efficacy studies monitor real-world drug experience and generate near real-time, predictive, and actionable intelligence. These insights help facilitate ongoing safety and effectiveness and support compliance with post-approval FDA and EMA requirements.

Safety research

Safety research delivers timely and actionable safety intelligence by analyzing complex, real-world data from EHRs, insurance claims, and other secondary sources to help identify potential risks in everyday product use.

Product use studies

Product use studies assess real-world patterns, behaviors, and the potential impact of reduced-harm products through randomized trials, actual use data, topography, biomarkers, and health/activity tracking.

Other real-world evidence and regulatory studies

Primary, secondary, and hybrid studies—utilizing quantitative and qualitative methods, EHR, claims, and other data sources—serve as sources for generating ongoing regulatory and real-world intelligence through flexible research solutions.

Perception and intention studies

Perception and intention studies examine the beliefs, motivations, and behaviors that influence product adoption, providing essential insights for regulatory and behavioral impact evaluation.

Post-market surveillance

Post-market surveillance monitors product use and perceptions over time by tracking trends across youth and adult populations, generating real-world intelligence through cross-sectional and longitudinal studies.

Behavioral insights

The STAR brand tool provides comprehensive analysis to uncover the behaviors that underpin prescribing choices, delivering clear direction on activation levels and barriers for brands.

Disease landscape

Tailored for early (Phase I/II) development, disease landscape includes assessment of unmet needs, the competitive landscape, epidemiology, standards of care, and performance benchmarks, leveraging Oracle Life Sciences CancerMPact and customized insights.

Market access

Driven by data, technology, and expertise, this offering provides guidance on launch pricing, price sensitivity and elasticity, reimbursement, and health technology assessment (HTA) submissions to support successful market access.

Parallel import tracking

Parallel import tracking is a syndicated survey that determines the percentage of parallel imports sourced from each country of origin. It enables the accurate allocation of stock and identification of missing elements when combined with sales and ex-factory data.

Brand equity

Our healthcare-specific brand equity framework measures current and potential brand equity, supplying the insights required to help drive brand optimization.

Epidemiology

Customized epidemiology solutions deliver novel patient segments, additional indications or geographies, and proprietary EHR-based estimates, helping address scenarios beyond standard Oracle Life Sciences offerings.

Oncology market tracking

Oncology market tracker is a robust patient chart–based methodology that provides accurate, real-world market shares. It enables in-depth analysis by patient segment and treatment setting with quarterly tracking of brand performance.

Social media listening

Social media listening analyzes online conversation, providing visibility into brand sentiment, competitor activity, and the impact of congress events. The resulting insights help refine messaging and engagement strategies.

Brand tracking

Brand tracking provides ongoing monitoring of product health, perception, and market performance, delivering insights into how a brand is viewed by healthcare providers, patients, and payers.

Launch strategy

Launch excellence programs offer clinical trial optimization, landscape assessments, patient journey mapping, stakeholder segmentation, communications management, and ongoing brand performance support.

Opportunity assessment

Research-driven evaluation—such as opportunity assessment, epi forecasting, and demand assessment—inform Phase II/III strategies. These assessments encompass target product profile (TPP) evaluation, likelihood to prescribe, adoption drivers and barriers, commercial positioning, and forecasting.

Chart review

Via online chart review, healthcare providers contribute to real-world data from medical records or electronic health system charts, offering valuable information on treatment patterns, outcomes, and patient characteristics.

Public health

Our research experts perform in-depth technological analyses of United States and European Union public health to reveal health trends, disease burdens, treatment effectiveness, and healthcare system outcomes across populations.

Direct-to-stakeholder quantitative studies

Structured data collection from patients, healthcare providers, or payers—via surveys and digital tools—yields measurable insights on treatment patterns, outcomes, and decision-making.

Real-world qualitative studies

Our real-world qualitative methods—including interviews, groups, and workshops with patients, providers, and caregivers—integrate creative, immersive, and human techniques within robust evidence generation methodologies.

Patient registries

Our experts build tech-enabled registry solutions to meet a variety of needs. Technology-enabled patient registry solutions can address a range of needs, whether using primary data (new data from patients or healthcare providers), secondary data (existing EHRs, claims, lab results), or mixed approaches for rich longitudinal insights.

Stakeholder preference

Optimal stakeholder preference methodologies—such as discrete choice experiments (DCE), best-worst scaling (BWS), patient characteristics DCE, and situational choice DCE—provide clarity on product preferences.

EHR and claims analysis

Oracle Life Sciences Linked Data combines EHR and claims data for a comprehensive view of patient care, enabling the tracking of treatment patterns, healthcare utilization, and outcomes by linking clinical details with billing data.

Unstructured EHR analysis

EHR analysis using unstructured notes—the natural language processing of free-text clinical narratives written by healthcare providers within our EHR—enables the extraction of valuable insights including treatment trends, patient symptoms, and physician observations.

National health and wellness survey

Oracle Life Sciences National Health and Wellness Survey is a global patient-reported outcome survey capturing health status, behaviors, and outcomes in 12 countries. It assesses physical and mental health, treatment patterns, quality of life, and healthcare utilization across more than 200 conditions.

Structured EHR analysis

Through structured EHR data analysis—including fields such as diagnoses, lab results, and medications—our researchers can easily extract insights on patient outcomes, treatment patterns, and disease trends from real-world clinical settings.

Cancer landscape

The Oracle Life Sciences CancerMPact cancer landscape dashboard enables an in-depth understanding of clinical development by drug class, technology, molecular target, indication, trial phase, and more through its standardized filters.

Cancer treatment trends

The Oracle Life Sciences CancerMPact treatment architecture trends module identifies trends in oncology treatment patterns, visualized by geography and physician specialty via a dedicated dashboard.

Oncology market decision support

Oracle Life Sciences CancerMPact is comprised of five cloud-based modules that cover epidemiology, treatment patterns and drug utilization, as well the current and future treatment landscape for more than 30 tumor types in the United States, Western Europe, Japan, and China. Modules are available individually or as a group by region.

Cancer patient metrics

The Oracle Life Sciences CancerMPact patient metrics and biomarker analysis module delivers market sizing for cancer treatments—including proprietary modeling and projection methodologies—informed by trusted global registry, literature, and research resources. Biomarker analysis includes systematic reviews of incidence rates and correlations for select actionable cancer biomarkers and tumor types.

Epidemiology insights

Oracle Life Sciences Epi Database provides access to epidemiology insights grounded in rigorous research and methodologies. It provides market sizing for 240+ indications across 19 therapeutic areas in the United States, Western Europe, Japan, China, Brazil, India, and the Russian Federation.

Cancer treatment architecture

Oracle Life Sciences CancerMPact treatment architecture offers coverage of all stages, modalities, lines of therapy, actionable biomarker segments, and other select segments.

Future cancer trends and insights

The Oracle Life Sciences CancerMPact future trends and insights module supports the exploration of profiles of drugs and regimens in pivotal development, delivering clarity on their potential to reshape the treatment landscape and their competitive positioning.